US medical manufacturer fined 2.8Mln US dlrs for false procedure claims

February 8, 2015 10:08 am 

WASHINGTON, Feb. 7 — Medical equipment manufacturer Medtronic will pay the United States government 2.8 million US dlrs for causing physicians to submit false claims for an unregulated spinal cord stimulation procedure, the US Department of Justice (DOJ) announced in a press release.

“Medical device manufacturer Medtronic Inc. has agreed to pay the United States 2.8 million US dlres to resolve allegations under the False Claims Act that Medtronic caused certain physicians to submit false claims to federal health care programs for a medical procedure known as ‘SubQ stimulation,’” DOJ Assistant Attorney General, Joyce R. Branda, said on Friday.

The SubQ medical procedure is designed to relieve chronic back pain with electrical impulses from a spinal cord stimulator, but the therapy, according to the DOJ, did not obtain the required US Food and Drug Administration safety certification that doctors need to get reimbursed from US federal healthcare agencies, including Medicare.

According to its 2014 annual report, Medtronic is a 17 billion US dlrs global leader in medical technology that specializes in the design, manufacture and selling of cardiac, spinal and neurological therapy equipment used by customers and patients in 114 countries. (PNA/Sputnik)

LAM/SSC

Comments

Comments are closed.